vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and UNITED BANCORP INC (UBCP). Click either name above to swap in a different company.

UNITED BANCORP INC is the larger business by last-quarter revenue ($6.9M vs $6.2M, roughly 1.1× Alector, Inc.). On growth, UNITED BANCORP INC posted the faster year-over-year revenue change (8.6% vs -88.5%). UNITED BANCORP INC produced more free cash flow last quarter ($-1.3M vs $-184.1M). Over the past eight quarters, UNITED BANCORP INC's revenue compounded faster (-0.7% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

United Bank was an American bank headquartered in Hartford, Connecticut, and had locations throughout Connecticut, Massachusetts and Rhode Island. The bank was acquired in 2019 by People's United Financial and branches were rebranded or closed.

ALEC vs UBCP — Head-to-Head

Bigger by revenue
UBCP
UBCP
1.1× larger
UBCP
$6.9M
$6.2M
ALEC
Growing faster (revenue YoY)
UBCP
UBCP
+97.1% gap
UBCP
8.6%
-88.5%
ALEC
More free cash flow
UBCP
UBCP
$182.8M more FCF
UBCP
$-1.3M
$-184.1M
ALEC
Faster 2-yr revenue CAGR
UBCP
UBCP
Annualised
UBCP
-0.7%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALEC
ALEC
UBCP
UBCP
Revenue
$6.2M
$6.9M
Net Profit
$2.0M
Gross Margin
Operating Margin
28.7%
Net Margin
29.6%
Revenue YoY
-88.5%
8.6%
Net Profit YoY
-1696.9%
10.1%
EPS (diluted)
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
UBCP
UBCP
Q4 25
$6.2M
$6.9M
Q3 25
$3.3M
$8.1M
Q2 25
$7.9M
$8.0M
Q1 25
$3.7M
$7.5M
Q4 24
$54.2M
$6.3M
Q3 24
$15.3M
$7.4M
Q2 24
$15.1M
$7.4M
Q1 24
$15.9M
$7.0M
Net Profit
ALEC
ALEC
UBCP
UBCP
Q4 25
$2.0M
Q3 25
$-34.7M
$1.9M
Q2 25
$-30.5M
$1.9M
Q1 25
$-40.5M
$1.9M
Q4 24
$-2.1M
$1.8M
Q3 24
$-42.2M
$1.8M
Q2 24
$-38.7M
$1.7M
Q1 24
$-36.1M
$2.0M
Operating Margin
ALEC
ALEC
UBCP
UBCP
Q4 25
28.7%
Q3 25
-1153.6%
23.7%
Q2 25
-433.6%
24.2%
Q1 25
-1216.5%
24.5%
Q4 24
-13.4%
28.1%
Q3 24
-315.7%
23.9%
Q2 24
-302.4%
21.8%
Q1 24
-275.0%
30.7%
Net Margin
ALEC
ALEC
UBCP
UBCP
Q4 25
29.6%
Q3 25
-1063.4%
23.9%
Q2 25
-387.7%
24.0%
Q1 25
-1101.6%
24.9%
Q4 24
-3.8%
29.1%
Q3 24
-275.2%
24.7%
Q2 24
-256.4%
23.6%
Q1 24
-227.0%
28.5%
EPS (diluted)
ALEC
ALEC
UBCP
UBCP
Q4 25
$0.35
Q3 25
$-0.34
$0.34
Q2 25
$-0.30
$0.33
Q1 25
$-0.41
$0.32
Q4 24
$-0.02
$0.31
Q3 24
$-0.43
$0.31
Q2 24
$-0.40
$0.30
Q1 24
$-0.38
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
UBCP
UBCP
Cash + ST InvestmentsLiquidity on hand
$256.0M
$46.5M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$70.5M
Total Assets
$293.2M
$857.4M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
UBCP
UBCP
Q4 25
$256.0M
$46.5M
Q3 25
$291.1M
$45.7M
Q2 25
$307.3M
$49.7M
Q1 25
$354.6M
$36.4M
Q4 24
$413.4M
$19.6M
Q3 24
$457.2M
$37.8M
Q2 24
$503.3M
$37.6M
Q1 24
$562.1M
$46.9M
Total Debt
ALEC
ALEC
UBCP
UBCP
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
UBCP
UBCP
Q4 25
$30.6M
$70.5M
Q3 25
$57.7M
$66.5M
Q2 25
$71.2M
$59.7M
Q1 25
$94.6M
$60.8M
Q4 24
$126.8M
$63.5M
Q3 24
$118.9M
$65.5M
Q2 24
$150.6M
$60.6M
Q1 24
$178.9M
$63.2M
Total Assets
ALEC
ALEC
UBCP
UBCP
Q4 25
$293.2M
$857.4M
Q3 25
$335.3M
$866.8M
Q2 25
$356.4M
$847.9M
Q1 25
$408.3M
$830.7M
Q4 24
$468.3M
$816.7M
Q3 24
$516.0M
$825.5M
Q2 24
$570.7M
$821.8M
Q1 24
$635.5M
$834.0M
Debt / Equity
ALEC
ALEC
UBCP
UBCP
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
UBCP
UBCP
Operating Cash FlowLast quarter
$-184.0M
$10.5M
Free Cash FlowOCF − Capex
$-184.1M
$-1.3M
FCF MarginFCF / Revenue
-2951.3%
-19.2%
Capex IntensityCapex / Revenue
0.7%
171.0%
Cash ConversionOCF / Net Profit
5.14×
TTM Free Cash FlowTrailing 4 quarters
$-326.5M
$-819.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
UBCP
UBCP
Q4 25
$-184.0M
$10.5M
Q3 25
$-32.5M
$3.2M
Q2 25
$-49.0M
$3.8M
Q1 25
$-60.8M
$1.1M
Q4 24
$-55.0M
$8.4M
Q3 24
$-50.7M
$4.4M
Q2 24
$-62.8M
$-789.0K
Q1 24
$-61.3M
$3.6M
Free Cash Flow
ALEC
ALEC
UBCP
UBCP
Q4 25
$-184.1M
$-1.3M
Q3 25
$-32.5M
$-367.0K
Q2 25
$-49.1M
$1.5M
Q1 25
$-60.8M
$-594.0K
Q4 24
$-55.2M
$-1.2M
Q3 24
$-50.9M
$-1.7M
Q2 24
$-63.1M
$-1.5M
Q1 24
$-61.9M
$223.0K
FCF Margin
ALEC
ALEC
UBCP
UBCP
Q4 25
-2951.3%
-19.2%
Q3 25
-997.6%
-4.5%
Q2 25
-623.0%
18.3%
Q1 25
-1655.0%
-7.9%
Q4 24
-101.8%
-19.7%
Q3 24
-332.1%
-22.9%
Q2 24
-418.6%
-20.5%
Q1 24
-389.3%
3.2%
Capex Intensity
ALEC
ALEC
UBCP
UBCP
Q4 25
0.7%
171.0%
Q3 25
0.3%
43.7%
Q2 25
0.1%
29.0%
Q1 25
0.5%
22.0%
Q4 24
0.3%
152.8%
Q3 24
1.4%
82.8%
Q2 24
2.2%
9.8%
Q1 24
3.4%
48.6%
Cash Conversion
ALEC
ALEC
UBCP
UBCP
Q4 25
5.14×
Q3 25
1.64×
Q2 25
1.98×
Q1 25
0.57×
Q4 24
4.57×
Q3 24
2.42×
Q2 24
-0.45×
Q1 24
1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons